10.6084/m9.figshare.10610303.v1 Isao Kawaguchi Isao Kawaguchi Kazuaki Chayama Kazuaki Chayama Yuri Sanchez Gonzalez Yuri Sanchez Gonzalez Suchin Virabhak Suchin Virabhak Dominic Mitchell Dominic Mitchell Cammy Yuen Cammy Yuen Hiromitsu Kumada Hiromitsu Kumada A Cost-Effectiveness Analysis of Glecaprevir/Pibrentasvir Versus Existing Direct-Acting Antivirals to Treat Chronic Hepatitis C in Japan Adis Journals 2019 Cost-effectiveness Direct-acting antiviral Genotype 1–6 Hepatitis C virus Infectious disease Japan Pan-genotype 2019-12-03 10:06:49 Figure https://adisjournals.figshare.com/articles/figure/A_Cost-Effectiveness_Analysis_of_Glecaprevir_Pibrentasvir_Versus_Existing_Direct-Acting_Antivirals_to_Treat_Chronic_Hepatitis_C_in_Japan/10610303 <p><strong>Provide enhanced digital features for this article</strong><br> If you are an author of this publication and would like to provide additional enhanced digital features for your article then please contact <u>adisrapidplus@springer.com</u>.<br> <br> The journal offers a range of additional features designed to increase visibility and readership. All features will be thoroughly peer reviewed to ensure the content is of the highest scientific standard and all features are marked as ‘peer reviewed’ to ensure readers are aware that the content has been reviewed to the same level as the articles they are being presented alongside. Moreover, all sponsorship and disclosure information is included to provide complete transparency and adherence to good publication practices. This ensures that however the content is reached the reader has a full understanding of its origin. No fees are charged for hosting additional open access content.<br> <br> Other enhanced features include, but are not limited to:<br> • Slide decks<br> • Videos and animations<br> • Audio abstracts<br> • Audio slides</p>